A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma

References

• WangFSFanJGZhangZGaoBWangHYThe global burden of liver disease: the major impact of ChinaHepatology20146062099210825164003
   PubMed Web of Science ®Google Scholar
• BruixJQinSMerlePRESORCE InvestigatorsRegorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trialLancet201738910064566627932229
   PubMed Web of Science ®Google Scholar
• LiuZCNingFWangHFEpidermal growth factor and tumor necrosis factor α cooperatively promote the motility of hepatocellular carcinoma cell lines via synergistic induction of fibronectin by NF-κB/p65Biochim Biophys Acta2017186111 Pt A2568258228844984
   PubMed Web of Science ®Google Scholar
• JiaHYangQWangTRhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agentsBiochim Biophys Acta2016186071417143027091611
   PubMed Web of Science ®Google Scholar
• LeeMWRamanSSAsvadiNHRadiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: a 10-year intention-to-treat analysisHepatology20176561979199028170115
   PubMed Web of Science ®Google Scholar
• WangCWangHYangWMulticenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinomaHepatology20156151579159025284802
   PubMed Web of Science ®Google Scholar
• XieHYuHTianSWhat is the best combination treatment with transarterial chemoembolization of unresectable hepatocellular carcinoma? A systematic review and network meta-analysisOncotarget201785910050810052329245997
   PubMedGoogle Scholar
• IkemotoTShimadaMYamadaSPathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablationHepatol Res2017471233026990590
   PubMed Web of Science ®Google Scholar
• IwahashiSShimadaMUtsunomiyaTEpithelial-mesenchymal transition-related genes are linked to aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablationCancer Lett20163751475026940140
   PubMed Web of Science ®Google Scholar
• TangZKangMZhangBAdvantage of sorafenib combined with radiofrequency ablation for treatment of hepatocellular carcinomaTumori2017103328629128058713
   PubMed Web of Science ®Google Scholar
• DongSKongJKongFSorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablationBMC Cancer20151593926620566
   PubMed Web of Science ®Google Scholar
• RoskoskiRJrThe role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disordersPharmacol Res2018129658329408302
   PubMed Web of Science ®Google Scholar
• FornerAReigMBruixJHepatocellular carcinomaLancet2018391101271301131429307467
   PubMed Web of Science ®Google Scholar
• KimHAKimKAChoiJIComparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocolBMC Cancer201717187729268722
   PubMed Web of Science ®Google Scholar
• RimolaJDíaz-GonzálezÁDarnellAComplete response under sorafenib in patients with hepatocellular carcinoma: relationship with dermatologic adverse eventsHepatology Epub2017912
   Web of Science ®Google Scholar
• KongYSunLHouZApatinib is effective for treatment of advanced hepatocellular carcinomaOncotarget201786210559610560529285275
   PubMedGoogle Scholar
• KouPZhangYShaoWSignificant efficacy and well safety of apatinib in an advanced liver cancer patient: a case report and literature reviewOncotarget2017812205102051528103584
   PubMedGoogle Scholar
• LeeJEKimKLKimDApatinib-loaded nanoparticles suppress vascular endothelial growth factor-induced angiogenesis and experimental corneal neovascularizationInt J Nanomedicine2017124813482228740387
   PubMed Web of Science ®Google Scholar
• JeongJHNguyenHKLeeJESuhWTherapeutic effect of apatinib-loaded nanoparticles on diabetes-induced retinal vascular leakageInt J Nanomedicine2016113101310927462154
   PubMed Web of Science ®Google Scholar
• BarnesCOKovalevaEGFuXAssessment of microcrystal quality by transmission electron microscopy for efficient serial femto-second crystallographyArch Biochem Biophys2016602616826944553
   PubMed Web of Science ®Google Scholar
• ChenYFengFGaoXMiRNA153 reduces effects of chemotherapeutic agents or small molecular kinase inhibitor in HCC cellsCurr Cancer Drug Targets201515317618725714700
   PubMed Web of Science ®Google Scholar
• HouJHongZFengFA novel chemotherapeutic sensitivity-testing system based on collagen gel droplet embedded 3D-culture methods for hepatocellular carcinomaBMC Cancer201717172929117859
   PubMed Web of Science ®Google Scholar
• HuLDKongDQHuQFPreparation, characterization and in vivo evaluation of injectable long-acting curcumin microcrystalParticul Sci Technol Epub2017310
   Web of Science ®Google Scholar
• LiLKangLZhaoWmiR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effectCancer Lett2017400899828461244
   PubMed Web of Science ®Google Scholar
• AllardMKhoudourNRousseauBSimultaneous analysis of regorafenib and sorafenib and three of their metabolites in human plasma using LC-MS/MSJ Pharm Biomed Anal2017142424828494338
   PubMed Web of Science ®Google Scholar
• HeYZhouLGaoSDevelopment and validation of a sensitive LC-MS/MS method for simultaneous determination of eight tyrosine kinase inhibitors and its application in mice pharmacokinetic studiesJ Pharm Biomed Anal2017148657228965046
   PubMed Web of Science ®Google Scholar
• ZhaoJBaiZFengFCross-talk between EPAS-1/HIF-2α and PXR signaling pathway regulates multi-drug resistance of stomach cancer cellInt J Biochem Cell Biol201672738826783937
   PubMed Web of Science ®Google Scholar
• ChaoTITaiWTHungMHA combination of sorafenib and SC-43 is a synergistic SHP-1 agonist duo to advance hepatocellular carcinoma therapyCancer Lett2016371220521326679051
   PubMed Web of Science ®Google Scholar
• XuXFanZLiangCA signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivityNat Commun201781405928094252
   PubMed Web of Science ®Google Scholar
• FengFJiangQCaoSPregnane X receptor mediates Sorafenib resistance in advanced hepatocellular carcinomaBiochim Biophys Acta2018186241017103029369785
   PubMed Web of Science ®Google Scholar
• FeiYXiongYShenXCathepsin L promotes ionizing radiation-induced U251 glioma cell migration and invasion through regulating the GSK-3β/CUX1 pathwayCell Signal201844627129331585
   PubMed Web of Science ®Google Scholar
• LeeHWParkWJHeoYRParkTIParkSYLeeJHTERT-CLPTM1 locus polymorphism (rs401681) is associated with the prognosis of hepatocellular carcinomaOnco Targets Ther2017104853485829042796
   PubMed Web of Science ®Google Scholar
• MuaddiHAl-AdraDPBeecroftRLiver transplantation is equally effective as a salvage therapy for patients with hepatocellular carcinoma recurrence following radiofrequency ablation or liver resection with curative intentAnn Surg Oncol201825499199929327179
   PubMed Web of Science ®Google Scholar
• TongYYangHXuXEffect of a hypoxic microenvironment after radiofrequency ablation on residual hepatocellular cell migration and invasionCancer Sci2017108475376228182306
   PubMed Web of Science ®Google Scholar
• JiangzhengZCaiXHaoXLncRNA FUNDC2P4 down-regulation promotes epithelial-mesenchymal transition by reducing E-cadherin expression in residual hepatocellular carcinoma after insufficient radiofrequency ablationInt J Hyperthermia2018110
   Web of Science ®Google Scholar
• ValleseFMishraNMPagliariMHelicobacter pylori antigenic Lpp20 is a structural homologue of Tipα and promotes epithelial-mesenchymal transitionBiochim Biophys Acta20171861123263327128947343
   PubMed Web of Science ®Google Scholar
• AgibaAMNasrMAbdel-HamidSEldinABGeneidiASEnhancing the intestinal permeation of the chondroprotective nutraceuticals glucosamine sulphate and chondroitin sulphate using conventional and modified liposomesCurr Drug Deliv Epub2018122
   Web of Science ®Google Scholar